1. Home
  2. AVX vs LGVN Comparison

AVX vs LGVN Comparison

Compare AVX & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avax One Technology Ltd.

AVX

Avax One Technology Ltd.

HOLD

Current Price

$4.19

Market Cap

30.8M

Sector

Industrials

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$1.55

Market Cap

7.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVX
LGVN
Founded
2017
2014
Country
United States
United States
Employees
7
N/A
Industry
Metal Fabrications
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.8M
7.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
AVX
LGVN
Price
$4.19
$1.55
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $61.25
AVG Volume (30 Days)
★ 329.4K
70.7K
Earning Date
11-13-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 92.55
50.76
EPS
N/A
★ N/A
Revenue
★ $2,340,811.00
$709,000.00
Revenue This Year
$18,042.77
$46.15
Revenue Next Year
$12.21
$396.46
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 3348.10
N/A
52 Week Low
$0.35
$0.48
52 Week High
$7.38
$7.60

Technical Indicators

Market Signals
Indicator
AVX
LGVN
Relative Strength Index (RSI) 43.34 33.66
Support Level $3.02 $0.61
Resistance Level $6.25 $7.30
Average True Range (ATR) 0.69 0.22
MACD -0.20 -0.02
Stochastic Oscillator 7.05 17.83

Price Performance

Historical Comparison
AVX
LGVN

About AVX Avax One Technology Ltd.

AVAX One Technology Ltd is a digital infrastructure company focused on digital asset and computing infrastructure. The Company builds modular data centers in regions with access to energy resources, using behind-the-meter generation and microgrid design to provide compute capacity for AI and high-performance computing (HPC) workloads. In addition, the company mines Bitcoin in Alberta and Ohio, operating at a hashrate of approximately 300 PH/s. The Company also maintains an Avalanche digital asset treasury, accumulating AVAX and generating onchain yield through native staking and ecosystem participation.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: